Moderna, Inc. (MRNA) Gross profit 2018–2025
Moderna, Inc. (MRNA) annual gross profit history from SEC filings — each fiscal year as reported.
$1.1BFY2025 · since FY2018: $135.1M → $1.1B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.1B | -39.3% |
| FY2024 | $1.8B | -17.8% |
| FY2023 | $2.2B | -84.4% |
| FY2022 | $13.8B | -12.7% |
| FY2021 | $15.9B | +1894.2% |
| FY2020 | $795.0M | +1220.4% |
| FY2019 | $60.2M | -55.4% |
| FY2018 | $135.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More MRNA financial trends
MRNA RevenueMRNA Net incomeMRNA Net marginMRNA Gross marginMRNA Operating incomeMRNA Operating marginMRNA Operating cash flowMRNA Free cash flowMRNA Capital expendituresMRNA Return on equityMRNA Stock buybacksMRNA Dividends paidMRNA Total assetsMRNA Total liabilitiesMRNA Shareholders’ equityMRNA overview →